(E)-N'-(3-methoxybenzylidene)-5-(naphthalen-2-yl)-1H-pyrazole-3-carbohydrazide

ID: ALA4849293

PubChem CID: 5342734

Max Phase: Preclinical

Molecular Formula: C22H18N4O2

Molecular Weight: 370.41

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(/C=N/NC(=O)c2cc(-c3ccc4ccccc4c3)[nH]n2)c1

Standard InChI:  InChI=1S/C22H18N4O2/c1-28-19-8-4-5-15(11-19)14-23-26-22(27)21-13-20(24-25-21)18-10-9-16-6-2-3-7-17(16)12-18/h2-14H,1H3,(H,24,25)(H,26,27)/b23-14+

Standard InChI Key:  MPQBYPHKDGMLHF-OEAKJJBVSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   13.9032  -11.0816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9021  -11.9011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6101  -12.3101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6083  -10.6727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3169  -11.0780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3177  -11.8970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0262  -12.3041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7345  -11.8932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7298  -11.0711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0207  -10.6677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4341  -10.6558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1827  -10.9836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7258  -10.3730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3128   -9.6677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.5146   -9.8426    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5390  -10.4535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8759  -11.1980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.0153   -9.7894    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8285   -9.8699    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.3048   -9.2059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1180   -9.2864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4527  -10.0330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2651  -10.1137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7422   -9.4492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4012   -8.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5898   -8.6248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8751   -8.0362    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.6886   -8.1138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
  9 11  1  0
 13 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 25 27  1  0
 27 28  1  0
M  END

Associated Targets(Human)

SPHK1 Tchem Sphingosine kinase 1 (1990 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 370.41Molecular Weight (Monoisotopic): 370.1430AlogP: 4.00#Rotatable Bonds: 5
Polar Surface Area: 79.37Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.06CX Basic pKa: 2.14CX LogP: 4.05CX LogD: 4.04
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.41Np Likeness Score: -1.62

References

1. Butler KJ, Castro AA, Dwyer TS, Hardwick LM, Iacino MC, Manore SG, Mays KM, McGlade CA, Hair LN, Parker EW, Smith MR, Turnow MT, Wilson MR, Woodson SR, Cotham WE, Walla MD, Hurlbert JC, Christian Grattan T..  (2021)  Design, synthesis and analysis of novel sphingosine kinase-1 inhibitors to improve oral bioavailability.,  50  [PMID:34418572] [10.1016/j.bmcl.2021.128329]

Source